Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome?
D016263:AIDS-Associated Nephropathy / Q000188:drug therapy* / Q000378:metabolism*; D000818:Animals; D023241:Antiretroviral Therapy, Highly Active; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D006801:Humans; D018384:Oxidative Stress / Q000187:drug effects*
D017320:HIV Protease Inhibitors